121 related articles for article (PubMed ID: 3892359)
21. A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain.
Rose C; Camus A; Schwartz JC
Proc Natl Acad Sci U S A; 1988 Nov; 85(21):8326-30. PubMed ID: 3186727
[TBL] [Abstract][Full Text] [Related]
22. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
Bernardini F; Warburton MJ
Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
[TBL] [Abstract][Full Text] [Related]
23. Multiple cleavage sites of cholecystokinin heptapeptide by "enkephalinase".
Durieux C; Charpentier B; Fellion E; Gacel G; Pelaprat D; Roques BP
Peptides; 1985; 6(3):495-501. PubMed ID: 3906590
[TBL] [Abstract][Full Text] [Related]
24. Products of cholecystokinin (CCK)-octapeptide proteolysis interact with central CCK receptors.
Steardo L; Knight M; Tamminga CA; Chase TN
Neurosci Lett; 1985 Mar; 54(2-3):319-25. PubMed ID: 2986058
[TBL] [Abstract][Full Text] [Related]
25. Neurokinin B is hydrolysed by synaptic membranes and by endopeptidase-24.11 (enkephalinase) but not by angiotensin converting enzyme.
Hooper NM; Turner AJ
FEBS Lett; 1985 Oct; 190(1):133-6. PubMed ID: 2995126
[TBL] [Abstract][Full Text] [Related]
26. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
[TBL] [Abstract][Full Text] [Related]
27. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases.
Checler F; Vincent JP; Kitabgi P
J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159
[TBL] [Abstract][Full Text] [Related]
28. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
[TBL] [Abstract][Full Text] [Related]
29. Detailed immunoautoradiographic mapping of enkephalinase (EC 3.4.24.11) in rat central nervous system: comparison with enkephalins and substance P.
Pollard H; Bouthenet ML; Moreau J; Souil E; Verroust P; Ronco P; Schwartz JC
Neuroscience; 1989; 30(2):339-76. PubMed ID: 2473416
[TBL] [Abstract][Full Text] [Related]
30. Binding of the bidentate inhibitor [3H]HACBO-Gly to the rat brain neutral endopeptidase "enkephalinase".
Waksman G; Bouboutou R; Devin J; Besselievre R; Fournie-Zaluski MC; Roques BP
Biochem Biophys Res Commun; 1985 Aug; 131(1):262-8. PubMed ID: 3899113
[TBL] [Abstract][Full Text] [Related]
31. "Enkephalinase", a newly characterised dipeptidyl carboxypeptidase: properties and possible role in enkephalinergic transmission.
Schwartz JC; de la Baume S; Malfroy B; Patey G; Perdrisot R; Swerts JP; Fournie-Zaluski MC; Gacel G; Roques BP
Int J Neurol; 1980; 14(2-4):195-204. PubMed ID: 6311767
[No Abstract] [Full Text] [Related]
32. The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11.
Matsas R; Kenny AJ; Turner AJ
Biochem J; 1984 Oct; 223(2):433-40. PubMed ID: 6149747
[TBL] [Abstract][Full Text] [Related]
33. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A.
Migaud M; Durieux C; Viereck J; Soroca-Lucas E; Fournié-Zaluski MC; Roques BP
Peptides; 1996; 17(4):601-7. PubMed ID: 8804068
[TBL] [Abstract][Full Text] [Related]
34. Purification and partial characterization of a heat-resistant, cytosolic neuropeptidase from rat liver.
Janas RM; Marks DL; LaRusso NF
Biochem Biophys Res Commun; 1994 Jan; 198(2):574-81. PubMed ID: 8297367
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
Altstein M; Blumberg S; Vogel Z
Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of calf-brain enkephalinase A and B.
van Amsterdam JG; van Buuren KJ; de Jong AM; Soudijn W
Life Sci; 1983; 33 Suppl 1():109-12. PubMed ID: 6363851
[TBL] [Abstract][Full Text] [Related]
37. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases.
Konkoy CS; Davis TP
J Neurochem; 1995 Dec; 65(6):2773-82. PubMed ID: 7595577
[TBL] [Abstract][Full Text] [Related]
38. CCK-nitric oxide interaction in rat cortex, striatum and pallidum.
Ferraro G; Sardo P; Di Giovanni G; Di Maio R; La Grutta V
Comp Biochem Physiol C Toxicol Pharmacol; 2003 Aug; 135(4):425-33. PubMed ID: 12965187
[TBL] [Abstract][Full Text] [Related]
39. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
Marshall FH; Barnes S; Pinnock RD; Hughes J
Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
[TBL] [Abstract][Full Text] [Related]
40. Release of the heptapeptide Met-enkephalin-Arg6-Phe7 and of the octapeptide Met-enkephalin-Arg6-Gly7-Leu8 from rat striatum in vitro and their rapid inactivation.
Patey G; Cupo A; Chaminade M; Morgat JL; Rossier J
Life Sci; 1983; 33 Suppl 1():117-20. PubMed ID: 6664213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
